These findings demonstrate that VLP(+Vpx)-mediated SAMHD1 depletion is dose-dependent, and the extent of SAMHD1 depletion correspondingly curbs GBM cell proliferation. The gene discussed is SAMHD1; the disease is glioblastoma.